Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

filgrastim

View Patient Information
A recombinant, non-glycosylated cytokine which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF) isoform B, with immunomodulating activity. Filgrastim binds to and activates G-CSF receptors with the same biological activity and stability as the endogenous cytokine, thereby controlling the production, differentiation, and function of neutrophilic granulocyte progenitors.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:filgrastim XM02
filgrastim-aafi
filgrastim-ayow
filgrastim-sndz
G-CSF
granulocyte colony-stimulating factor
recombinant methionyl human granulocyte colony stimulating factor
tbo-filgrastim
Tbo-filgrastim
US brand name:Granix
Neupogen
Nivestym
Releuko
Zarxio
Foreign brand name:Nivestim
Tevagrastim
Abbreviation:G-CSF
r-metHuG-CSF
rG-CSF
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search